Ex Parte DRAKE et al - Page 6


                  Appeal No. 2003-0366                                                                                                                    
                  Application 09/349,759                                                                                                                  

                  products” and catalyst B exhibits a slightly lower rate of coking than catalyst C.  No statement is                                     
                  made with respect to the relative performance of the three catalysts regarding the “Composition                                         
                  of Gas Products,” of which ethylene and propylene are specified in the appealed claims.  While                                          
                  appellants do note that some results reported in Table I are “higher” and others “lower” with                                           
                  respect to steamed, silylated zeolite catalyst C representing appealed claim 36, there is no                                            
                  statement in either the brief or the specification of the practical significance of such results and                                    
                  there is no explanation or evidence bearing on whether such results would have been unexpected.                                         
                           Appellants further rely on the comparisons provided in specification Examples III and IV                                       
                  and the results thereof reported in specification Table II.  The comparisons involve an untreated                                       
                  ZSM-5 catalyst, designated “T-4480 Zeolite,” the acid-leached modification of that catalyst,                                            
                  designated “Acid Leached Zeolite,” and the silylated modification of the acid leached catalyst                                          
                  representing claim 15, designated “Silylated, Acid Leached Zeolite.”  Appellants state that the                                         
                  claimed silylated, acid leached ZSM-5 zeolite catalyst exhibited “significantly improved” weight                                        
                  ratio of lower olefin to aromatic and “significantly lower” reduced coking than the other zeolite                                       
                  catalysts in the brief (page 5) and in the specification (page 17).  We accept appellants’                                              
                  statements.  However, while appellants do note that the results are “significant” with respect to                                       
                  silylated, acid leached ZSM-5 zeolite catalyst representing appealed claim 15, there is no                                              
                  statement in either the brief or the specification of the practical significance of such results and                                    
                  there is no explanation or evidence bearing on whether such results would have been unexpected.                                         
                           The examiner submits that the comparisons are “not persuasive since a catalyst as                                              
                  disclosed by the closest art (Beck et al.) is not used to compared with the claimed catalyst” in                                        
                  each of the Tables, as “only an untreated zeolite and one-treatment-step zeolite are used to                                            
                  compare with the presently claimed” catalysts (answer, page 4).                                                                         
                           Upon carefully considering the objective evidence relied on, we agree with the                                                 
                  examiner’s position because in the absence of such a showing as deemed necessary by the                                                 
                  examiner, the evidence does not address the thrust of the examiner’s ground of rejection.  See                                          
                  e.g., Baxter Travenol Labs., 952 F.2d 388, 392, 21 USPQ2d 1281, 1285 (Fed. Cir. 1991)                                                   
                  (“[W]hen unexpected results are used as evidence of nonobviousness, the results must be shown                                           
                  to be unexpected compared with the closest prior art. [Citation omitted.]”); In re Burckel, 592                                         


                                                                          - 6 -                                                                           



Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007